(Q36249817)

English

A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Paweena Susantitaphong

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Siriwan Nakwan

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sadudee Peerapornratana

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Khajohn Tiranathanagul

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Pisut Katavetin

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Nattachai Srisawat

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Kearkiat Praditpornsilpa

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Somchai Eiam-Ong

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

14 January 2017

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

18

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

19

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Chronic kidney disease in low- and middle-income countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

Interactions of vitamin D and the proximal tubule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

Active vitamin D treatment for reduction of residual proteinuria: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

Prevalence of 25-OH vitamin D deficiency in a population of hemodialysis patients and efficacy of an oral ergocalciferol supplementation regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

Impact of vitamin D on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

1 October 2017

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

29 June 2018

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

29 June 2018

The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

22 September 2018

Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

22 September 2018

The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

22 September 2018

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

22 September 2018

Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

22 September 2018

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

22 September 2018

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5237567

22 September 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12882-017-0436-6

21 January 2018

Serum 1,25-dihydroxyvitamin d and the development of kidney dysfunction in a Japanese community

1 reference

https://pubmed.ncbi.nlm.nih.gov/28088187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/28088187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D and chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/28088187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/28088187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/28088187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12882-017-0436-6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36249817&oldid=1948339900"